The sector is ready, and the community needs Australian alcohol and other drug treatment services to ask about sexuality and gender identity.


Journal

Drug and alcohol review
ISSN: 1465-3362
Titre abrégé: Drug Alcohol Rev
Pays: Australia
ID NLM: 9015440

Informations de publication

Date de publication:
01 2022
Historique:
revised: 05 07 2021
received: 16 03 2021
accepted: 16 07 2021
pubmed: 10 8 2021
medline: 1 4 2022
entrez: 9 8 2021
Statut: ppublish

Résumé

Sexuality and gender diverse Australians are a priority population in federal and state-based alcohol and other drug (AOD) strategies. Research evidence shows higher prevalence of AOD use by lesbian, gay, bisexual, transgender and queer (LGBTQ) people, riskier use and a higher proportion have accessed AOD treatment. Despite these disparities, Australian AOD treatment services do not routinely collect data on sexuality or gender identity. As a result, the treatment needs, experiences and outcomes of LGBTQ people remain largely invisible. The Australian Bureau of Statistics' recently released standardised indicators for the recording of sex, gender, variations of sex characteristics and sexual orientation presents an opportunity for the AOD sector to implement inclusive data collection as a foundational step towards achieving policy priorities for LGBTQ people. This commentary includes an implementation case study from the New South Wales non-government AOD treatment sector, where sexuality and gender identity indicators have been collected since 2016.

Identifiants

pubmed: 34370883
doi: 10.1111/dar.13367
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

39-42

Informations de copyright

© 2021 Australasian Professional Society on Alcohol and other Drugs.

Références

Commonwealth of Australia Department of Health. National Drug Strategy 2017-2026. Canberra: Commonwealth of Australia Department of Health, 2017.
Australian Institute of Health and Welfare. National Drug Strategy Household Survey 2019. Canberra: AIHW, 2020 Available at: https://www.aihw.gov.au/getmedia/3564474e-f7ad-461c-b918-7f8de03d1294/aihw-phe-270-NDSHS-2019.pdf.
Callander D, Wiggins J, Rosenberg S et al. The 2018 Australian trans and gender diverse sexual health survey: report of findings. The Kirby Institute, UNSW Sydney: Sydney, NSW, 2019.
Broady T, Power C, Mao L et al. Gay Community periodic survey: Sydney 2019. Sydney: Centre for Social Research in Health Sydney, 2019.
Mooney-Somers J, Deacon R, Scott P, Price K, Parkhill N. Women in contact with the Sydney LGBTQ communities: report of the SWASH lesbian, bisexual and queer Women's health survey 2014, 2016, 2018. Sydney: Sydney Health Ethics, University of Sydney, 2018.
Green KE, Feinstein BA. Substance use in lesbian, gay, and bisexual populations: an update on empirical research and implications for treatment. Psychol Addict Behav 2012;26:265-78.
Fish JN. Sexual orientation-related disparities in high-intensity binge drinking: findings from a nationally representative sample. LGBT Health 2019;6:242-9.
Roxburgh A, Lea T, de Wit J, Degenhardt L. Sexual identity and prevalence of alcohol and other drug use among Australians in the general population. Int J Drug Policy 2016;28:76-82.
Mooney-Somers J, Deacon RM, Anderst A et al. Women in contact with the Sydney LGBTIQ communities: report of the SWASH lesbian, bisexual and queer Women's health survey 2016, 2018, 2020. Sydney: Sydney Health Ethics, University of Sydney, 2020.
Hammoud MA, Bourne A, Maher L et al. Intensive sex partying with gamma-hydroxybutyrate: factors associated with using gamma-hydroxybutyrate for chemsex among Australian gay and bisexual men - results from the flux study. Sex Health 2018;15:123-34.
Tomkins A, George R, Kliner M. Sexualised drug taking among men who have sex with men: a systematic review. Perspect Public Health 2018;139:23-33.
Hyde ZDM, Tilley PJM, McCaul KA, Rooney R, Jancey J. The first Australian National Trans Mental Health Study: summary of results. Perth: School of Public Health, Curtin University, 2014.
Mullens AB, Fischer J, Stewart M, Kenny K, Garvey S, Debattista J. Comparison of government and non-government alcohol and other drug (AOD) treatment service delivery for the lesbian, gay, bisexual, and transgender (LGBT) community. Subst Use Misuse 2017;52:1027-38.
Pride In Health and Wellbeing. Infographic of LGBT barriers to care and health disparities. Sydney: NSW, 2020 Available at: http://www.prideinhealth.com.au/blog/infographic-of-lgbt-barriers-to-care-and-health-disparities/.
Bryant J, Horwitz R, Gray R et al. Access and equity project, barriers and enablers associated with access and equity in alcohol and other drug treatment in NSW. UNSW Sydney: Centre for Social Research and Health, 2020.
Allen JL, Mowbray O. Sexual orientation, treatment utilization, and barriers for alcohol related problems: findings from a nationally representative sample. Drug Alcohol Depend 2016;161:323-30.
Bourne A, Reid D, Hickson F, Torres-Rueda S, Weatherburn P. Illicit drug use in sexual settings ('chemsex') and HIV/STI transmission risk behaviour among gay men in South London: findings from a qualitative study. Sex Transm Infect 2015;91:564-8.
Lea T, Ryan D, Prestage G et al. Alcohol use among a community-based sample of gay men: correlates of high-risk use and implications for service provision. Drug Alcohol Rev 2015;34:349-57.
Lea T, Brener L, Whitlam G, Gray R, Lambert S, Holt M. Evaluation of ACON's substance support service. Sydney: UNSW Centre for Social Research in Health and ACON, 2020.
Nuttbrock LA. Culturally competent substance abuse treatment with transgender persons. J Addict Dis 2012;31:236-41.
Senreich E. The substance abuse treatment experiences of a small sample of transgender clients. J Soc Work Pract Addict 2011;11:295-9.
Ruth S, Parkhill N, Reynolds R. A response to Pienaar et al (2018) ‘problematizing LGBTIQ drug use, governing sexuality and gender: a critical analysis of LGBTIQ health policy in Australia’. Int J Drug Policy 2018;55:195-6.
Queensland Mental Health Commission. Shifting minds, Queensland Mental Health, Alcohol and Other Drugs Strategic Plan 2018-2023. 2018.
State Government of Victoria. Victoria's ice action plan. Melbourne: State Government of Victoria, 2015.
Commonwealth of Australia. National Ice Action Strategy 2015. 2015.
NSW Department of Health. Drug and alcohol plan 2006-2010. Sydney: NSW Department of Health, NSW, 2007.
Australian Bureau of Statistics. Standard for sex, gender, variations of sex characteristics and sexual orientation variables. Canberra, Australia: Australian Bureau of Statistic, 2020 Available at: https://www.abs.gov.au/statistics/standards/standard-sex-gender-variations-sex-characteristics-and-sexual-orientation-variables/2020.
World Health Organisations, UNAIDS, United Nations Development Program. International Guidelines on Human Rights and Drug Policy. 2019.
NHS England. Sexual Orientation Monitoring, Full Specification. London, UK, Available at:: NHS England, 2017. https://www.england.nhs.uk/publication/sexual-orientation-monitoring-full-specification/.
Health Resources and Service Administation. Program assistance letter, approved uniform data system changes for calendar year 2016. Washington, DC: US Department of Health and Human Services, 2016.
Skinner NMA, Roche A. Australia's alcohol and other drug workforce: National Survey Results 2019-2020. Adelaide, South Australia: National Centre for Education and Training on Addiction (NCETA), Flinders University, 2020.
NADA. Asking the question, recommended sexuality and gender indicators. Sydney: NADA, 2020 Available at: https://www.nada.org.au/resources/elearning/.
ACON, NADA. Central eastern Sydney primary health network. Sydney, NSW: AOD LGBTIQ Inclusive Practice Guidelines For Treatment Providers, 2019.
ACON. Rainbow buzz: LGBTQ inclusive practice for AOD support services in-person training. Sydney: NSW, 2020 Available at: https://www.pridetraining.org.au/products/rainbow-buzz-lgbtq-inclusive-practice-inperson-training.
ACON. About pride in health and wellbeing. Sydney: NSW, 2020. https://www.prideinclusionprograms.com.au/health/.
Grasso C, McDowell MJ, Goldhammer H, Keuroghlian AS. Planning and implementing sexual orientation and gender identity data collection in electronic health records. J Am Med Inform Assoc 2019;26:66-70.
Suen LW, Lunn MR, Katuzny K et al. What sexual and gender minority people want researchers to know about sexual orientation and gender identity questions: a qualitative study. Arch Sex Behav 2020;49:2301-18.

Auteurs

Jack Freestone (J)

Alcohol and Other Drug Research and Development, ACON, Sydney, Australia.

Julie Mooney-Somers (J)

Sydney Health Ethics, School of Public Health, University of Sydney, Sydney, Australia.

Suzie Hudson (S)

Network of Alcohol and Other Drug Agencies, Sydney, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH